Article

Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 Variants

2022-07-28

Abstract excerpt

The Coronavirus disease 19 (COVID-19) pandemic has accumulated over 550 million confirmed cases and more than 6.34 million deaths worldwide. Although vaccinations has largely protected the population through the last two years, the effect of vaccination has been increasingly challenged by the emerging SARS-CoV-2 variants. Although several therapeutics including both monoclonal antibodies and small molecule drugs h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a17bb8c0-77bb-54cc-96de-ef51cbd00667
DOI: 10.1101/2022.07.27.501719

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 VariantsDOI 10.1101/2022.07.27.501719Read

Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2Semantic proximity Read

Development of equine antisera with high neutralizing activity against SARS-CoV-2Semantic proximity Read

Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheepSemantic proximity Read

Understanding host responses to equine encephalitis virus infection: implications for therapeutic developmentSemantic proximity Read

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsSemantic proximity Read

Equine Influenza Virus: An Old Known Enemy in the AmericasSemantic proximity Read

Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicitySemantic proximity Read

Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animalsSemantic proximity Read

Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variantSemantic proximity Read

SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibodySemantic proximity Read

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsSemantic proximity Read

Observational study: Application of Therapy with Equine Serum for Patients Diagnosed with COVID-19 in Tucumán, ArgentinaSemantic proximity Read